Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
NG2-targeting macrophages inhibit 3D invasion of patient-derived glioblastoma spheroids.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
Positron Emission Tomography of CD47/SIRPα Axis and Image-Informed Therapeutic Design.
Journal: bioRxiv : the preprint server for biology
Published: February 09, 2026
Surgical outcomes in pediatric idiopathic intracranial hypertension: a systematic review and meta-analysis of CSF shunting, optic nerve sheath fenestration, and venous sinus stenting.
Journal: Neurosurgical focus
Published: August 15, 2025
Laser ablation of a fourth ventricular hamartoma causing medically refractory hemifacial spasms in a child: illustrative case.
Journal: Journal of neurosurgery. Case lessons
Published: October 17, 2024
Evaluating Methodology for Increasing Diversity in US Residency Training Programs: A Scoping Review.
Evaluating Methodology for Increasing Diversity in US Residency Training Programs: A Scoping Review.
Journal: Journal of graduate medical education
Published: September 15, 2024
Human CSPG4-targeting CAR-macrophages inhibit melanoma growth.
Journal: Oncogene
Published: August 28, 2024
CSPG4-targeting CAR-macrophages inhibit melanoma growth.
Journal: bioRxiv : the preprint server for biology
Published: June 19, 2024
Computational and biological modeling of IGF1R inhibition for multifocal medulloblastoma.
Journal: Communications medicine
Published: April 22, 2024
Robotic radiosurgery for the treatment of pediatric arteriovenous malformations.
Journal: Journal of neurosurgery. Pediatrics
Published: April 19, 2024
An international study presenting a federated learning AI platform for pediatric brain tumors.
Journal: Nature communications
Published: January 04, 2024
Morphological and ultrastructural investigation of the posterior atlanto-occipital membrane: Comparing children with Chiari malformation type I and controls.
Journal: PloS one
Published: September 28, 2023
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.
Journal: Journal for immunotherapy of cancer
Published: December 13, 2022
Last Updated: 09/26/2026